Skip Navigation

COVID-19 Update

We continue to monitor COVID-19 cases in our area and providers will notify you if there are scheduling changes. Please continue to call your providers with health concerns. We are providing in-person care and telemedicine appointments.

Learn about our expanded patient care options and visitor guidelines.

General Information | Self-Checker | Donate and Lend Support | Staff Appreciation | Get Email Alerts


NeuroLogic Winter 2019

Download Issue PDF
NeuroLogic Winter 2019

First Effective Treatment for Transthyretin Amyloidosis

Johns Hopkins research into rare disease leads to approval of the first drug that can halt its progression.
back to top button